US Nuclear (UCLE) AI Stock Analysis

• Market Cap: $1.20M
• Dividend Yield: N/A
• Average Volume (3M): 8.69K
• Price to Earnings (P/E): ―
• Beta (1Y): -15.01
• Revenue Growth: -1.82%
• EPS Growth: 59.27%
• Country: US
• Employees: 8
• Sector: Technology
• Sector Strength: 91
• Industry: Hardware, Equipment & Parts
• EPS (TTM): >-0.01
• Shares Outstanding: 59,629,204
• 10 Day Avg. Volume: 15,993
• 30 Day Avg. Volume: 8,686
• PEG Ratio: -0.07
• Price to Book (P/B): -2.30
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -4.16
• Enterprise Value/Market Cap: 3.13
• Enterprise Value/Revenue: 0.41
• Enterprise Value/Gross Profit: 3.71
• Enterprise Value/Ebitda: -0.69
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: $0.00 ▼(-100.00%Downside)

US Nuclear's overall stock score is driven by its poor financial performance, characterized by negative equity, high leverage, and cash flow issues. Technical analysis indicates a bearish trend, and valuation metrics show unattractiveness due to negative earnings. Addressing these financial challenges is critical for any potential improvement in the stock's outlook.

US Nuclear Business Overview & Revenue Model

Company Description

US Nuclear Corp., together with its subsidiaries, engages in the developing, manufacturing, and selling radiation detection and measuring equipment worldwide. It operates through two segments, Optron and Overhoff. The company offers radiation water monitors that allow the detection of radioactive materials in drinking water, ground water, rainfall, rivers, and lakes; alpha, beta, gamma, and neutron monitors; DroneRAD aerial radiation detection; air and water monitors; and nano-second X-ray monitors. It also provides vehicle, personnel, exit, and room monitors; radon air monitors and radon switch products to determine the radon content in the air in basements, mills, mines, and buildings; handheld survey meters, as well as personal dosimeters and pocket micro-R meters; and port security equipment. In addition, the company offers software, which measures gamma and neutron radiation levels; airborne radioactivity levels; temperature and humidity in the facility; status of security doors; wind speed and direction; and barometric pressure. Its products and services are used in nuclear reactor plants, universities, local and state hospitals, government agencies, and emergency medical technicians/first responders, as well as in airports, cargo, screening as ports and borders, and other critical infrastructure. The company is headquartered in Canoga Park, California.

How the Company Makes Money

US Nuclear Corp generates revenue primarily through the sale of its radiation detection and monitoring equipment. The company's key revenue streams include direct sales to end-users such as nuclear power plants, hospitals, and military organizations, as well as sales through distribution partners and resellers. Additionally, US Nuclear may engage in service contracts for the maintenance and calibration of their devices, providing an additional revenue stream. Significant partnerships with governmental and industrial entities can also contribute to its earnings, as they allow access to large-scale projects and contracts requiring specialized radiation detection solutions.

US Nuclear Financial Statement Overview

Summary

US Nuclear is struggling financially, with ongoing losses and high leverage. Negative equity and cash flow issues present significant risks. Revenue growth is inconsistent, and profitability remains a challenge.

Income Statement

The company has consistently reported negative net income, indicating ongoing losses. The gross profit margin is moderate but insufficient to cover operating expenses, leading to negative EBIT and EBITDA margins. Revenue growth has been inconsistent, showing a decline in recent years.

Balance Sheet

The balance sheet reveals a concerning financial structure with negative stockholders' equity, indicating liabilities exceed assets. The debt-to-equity ratio is effectively infinite due to negative equity, highlighting high financial leverage and potential risk. The equity ratio is negative, further emphasizing financial instability.

Cash Flow

The cash flow statement shows persistent negative free cash flow, indicating cash outflows exceed inflows. The operating cash flow to net income ratio is negative, reflecting cash flow challenges. Financing activities have been the main source of cash, but this is unsustainable in the long term.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.19M	2.23M	2.09M	2.14M	1.75M
Gross Profit	1.02M	924.31K	788.07K	1.38M	474.51K
EBITDA	-1.51M	-1.78M	-1.49M	-1.81M	-2.87M
Net Income	-1.74M	-3.43M	-2.59M	-1.89M	-4.05M
Balance Sheet
Total Assets	2.65M	2.86M	3.11M	2.85M	2.45M
Cash, Cash Equivalents and Short-Term Investments	130.84K	152.84K	126.11K	246.32K	227.30K
Total Debt	1.78M	2.24M	1.60M	910.27K	825.48K
Total Liabilities	3.50M	4.84M	3.46M	2.41M	1.61M
Stockholders Equity	-856.16K	-1.98M	-348.30K	441.27K	847.16K
Cash Flow
Free Cash Flow	-509.05K	-264.30K	-1.32M	-447.47K	-614.15K
Operating Cash Flow	-509.05K	-263.44K	-1.32M	-441.03K	-614.15K
Investing Cash Flow	-30.77K	-24.55K	0.00	-21.45K	-235.00K
Financing Cash Flow	517.82K	314.72K	1.20M	481.49K	-11.21K

US Nuclear Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.02 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UCLE.

US Nuclear Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ELTK	70 Outperform	$70.26M	20.28	8.80%	1.82%	1.05%	-51.90%
MIND	67 Neutral	$69.81M	44.56	12.53%	―	22.59%	―
Sector *	63 Neutral	$34.78B	5.17	-11.38%	1.67%	5.54%	-17.15%
CPSH	61 Neutral	$37.48M	―	-18.07%	―	-13.83%	-476.23%
LPTH	55 Neutral	$137.28M	―	-24.86%	―	2.59%	-48.02%
GNSS	47 Neutral	$80.83M	―	-131.75%	―	-20.77%	-2.08%
UCLE	39 Underperform	$1.20M	―	1281.72%	―	-1.82%	59.27%